Ignite Creation Date:
2025-12-24 @ 2:43 PM
Ignite Modification Date:
2026-01-04 @ 12:13 AM
Study NCT ID:
NCT03936959
Status:
TERMINATED
Last Update Posted:
2025-01-15
First Post:
2019-04-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced Cancer
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-24
Start Date Type:
ACTUAL
Primary Completion Date:
2020-03-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-29
Completion Date Type:
ACTUAL
First Submit Date:
2019-04-26
First Submit QC Date:
None
Study First Post Date:
2019-05-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-08-05
Results First Submit QC Date:
None
Results First Post Date:
2025-01-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-09
Last Update Post Date:
2025-01-15
Last Update Post Date Type:
ACTUAL